Christine Windemuth-Kieselbach

Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial

Lisa Zimmer, Elisabeth Livingstone, Jessica C. Hassel et al. · The Lancet · 2020 · 242 citations

Medicine, Immunology, Oncology +14

Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center

Christian Jacob, Jasmin Romanos, Astrid Dempfle et al. · European Archives of Psychiatry and Clinical Neuroscience · 2007 · 239 citations

Medicine, Psychiatry, Psychology +17

Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns—Results of a non-interventional study of the DeCOG

Uwe Hillen, Ulrike Leiter, Sylvie Haase et al. · European Journal of Cancer · 2018 · 124 citations

Medicine, Dermatology, Oncology +13

Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12

Marcel Romanos, Christine M. Freitag, Christian Jacob et al. · Molecular Psychiatry · 2008 · 112 citations

Life Sciences, Genetics, Molecular Genetics +15

Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial

Elisabeth Livingstone, Lisa Zimmer, Jessica C. Hassel et al. · The Lancet · 2022 · 108 citations

Medicine, Immunology, Oncology +16